1. Home
  2. STEM vs ELTX Comparison

STEM vs ELTX Comparison

Compare STEM & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stem Inc.

STEM

Stem Inc.

SELL

Current Price

$4.26

Market Cap

56.6M

Sector

Technology

ML Signal

SELL

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$1.89

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEM
ELTX
Founded
2009
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.6M
63.3M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
STEM
ELTX
Price
$4.26
$1.89
Analyst Decision
Hold
Buy
Analyst Count
6
4
Target Price
$7.45
★ $13.67
AVG Volume (30 Days)
169.5K
★ 335.3K
Earning Date
10-28-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.29
EPS
N/A
★ N/A
Revenue
★ $156,266,000.00
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.49
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 8.08
N/A
52 Week Low
$3.70
$1.71
52 Week High
$32.23
$16.00

Technical Indicators

Market Signals
Indicator
STEM
ELTX
Relative Strength Index (RSI) 40.24 30.64
Support Level $3.70 $1.71
Resistance Level $6.02 $3.32
Average True Range (ATR) 0.30 0.12
MACD 0.02 0.05
Stochastic Oscillator 49.11 53.97

Price Performance

Historical Comparison
STEM
ELTX

About STEM Stem Inc.

Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: